Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Positive data from phase 2 NOBLE study of pegcetacoplan presented as late-breaker at ERA congress

· Rapid reduction in disease activity seen at 12 weeks sustained at one year · 55% of patients showed zero C3c staining intensity, indicating that C3c deposits cleared · Highlighted as late-breaking oral presentation at the European Renal Association (ERA) Congress Sobi® and Apellis Pharmaceuticals, Inc. today announced positive one-year results from the phase 2 NOBLE study investigating systemic pegcetacoplan, a targeted C3 therapy, for the treatment of post-transplant recurrence of C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-

Norse Atlantic ASA: Notice of annual general meeting

Arendal, 24 May 2024: Norse Atlantic ASA (the "Company") hereby calls for its annual general meeting to be held on Friday, 14 June 2023 at 09:00 CEST. The meeting will be held electronically. The notice of the general meeting, including the board's proposed resolutions, the notice of attendance and the proxy form, is attached to this notice. Shareholders are encouraged to attend the meeting by casting their votes in advance or granting a proxy to the chair of the board with voting instructions. See further details in the attached notice. The notice of the general meeting with

Bio-Works Chairman Peter Ehrenheim: “Significant Changes for Success and Profitability”

At Bio-Works’ Annual General Meeting on May 24, Chairman of the Board Peter Ehrenheim addressed the company’s shareholders and employees with an evaluation of the company’s operations and future direction:“It is no secret that Bio-Works has not developed according to the expectations set by the board  over the past year. We have faced several challenges that have affected upon our growth and profitability”, said Ehrenheim. He emphasized that despite these challenges, the board strongly believes in Bio-Works’ business-idea and its potential for success. Ehrenheim highlighted: “Bio-Works

Salsa Rolls out Air Dice Content onto Salsa Gator Offering

Salsa Technology is excited to announce it has signed a new content partnership with renowned Finnish dice game and online casino provider, Air Dice.Also part of the Air Dice group are the renowned Dice Crafter and Probability Jones studios. Together with Air Dice, each of the brands will now be seamlessly accessible through Salsa Gator. Air Dice studio’s leading title is Mega Top Shot, Dice Crafter’s is Star Shine, and Probability Jones’ is Flaming Bombs. Each of the studios under the Air Dice group has built a stellar reputation for a diverse and engaging portfolio of games that

Norconsult ASA: Mandatory notification of trade by primary insider

Sandvika, 24 May 2024 (OSE: NORCO): Mari Thjømøe, board member in Norconsult ASA, has today 24 May 2024 through Thjømøekranen AS purchased 10,000 shares in the Company at a price of NOK 30 per share. Following the transaction, Mari Thjømøe, holds a total number of 31,052 shares in the Company. For further information, please contact: Investors: Elin Spieler, Head of Treasury and IR Manager, IR@norconsult.com                                                                  Media: Henrik Charlesen, Senior Communication Advisor, Henrik.Charlesen@norconsult.com This information is

SOFTSWISS’ Values Fest Among Best Corporate Events 2024

SOFTSWISS, an international tech company with over 15 years of expertise in iGaming, celebrates its recognition at the Global Eventex Awards, the world’s leading accolade in the sphere of events and experiential marketing.The Global Eventex Awards recognise outstanding achievements and creativity in event organisation. For the 2024 awards, winners were selected from over 1,200 applications spanning 62 countries and six continents. Among outstanding competitors such as Lufthansa, Unilever, Vodafone, Cisco, and many others, SOFTSWISS’ Values Fest won bronze in the Corporate Event category (

Correction: Norconsult ASA - Mandatory notification of trade by primary insider

Sandvika, 24 May 2024 (OSE: NORCO): Reference is made to the stock exchange notice dated 21 May 2024 regarding that Karl Erik Kjelstad, board member in Norconsult ASA (the “Company”), had purchased 30,000 shares in the Company at a price of NOK 30 per share. The transaction was carried out through Byesvollen AS, a closely associated company of Karl Erik Kjelstad. Please see attached notification form where this is corrected. Following the transaction, Karl Erik Kjelstad and his close associates hold a total number of 30,000 shares in the Company. For further information, please

Getinge and UpBeat Clean: Cleaning Up for a positive change in Derby

We're excited to announce a positive collaboration between Getinge and Upbeat Clean, a dynamic social enterprise in Derby. As a global MedTech leader, we're always on the lookout for meaningful partnerships, and this one is particularly special. Upbeat Clean, a brainchild of Upbeat Communities, has been positively impacting the lives of refugees and asylum-seekers for over 15 years. Their commitment recently earned them the prestigious Marketing Derby's Rising Star Award – a well-deserved accolade. Upbeat Clean is our chosen commercial cleaning partner for the UK Head Office.

Vår Energi sells Bøyla asset as part of portfolio optimisation

Sandnes, Norway 24 May 2024: Vår Energi ASA (OSE: VAR) has signed an agreement with Concedo AS for the disposal of a 20% interest in the Bøyla field for a consideration of USD 24 million. "The transaction is aligned with our stated ambition to dispose of non-strategic assets to optimise our portfolio of assets; reducing our operating costs and emission outlook and enhance future value creation” says Stefano Pujatti, CFO of Vår Energi. The transaction is subject to customary regulatory approvals and is expected to close in the fourth quarter 2024, with effective date 1 January 2024.

Notice to attend Annual General Meeting in Artificial Solutions International AB

The shareholders of Artificial Solutions International AB (publ), reg. no. 556840-2076 (the “Company”), are hereby invited to the Annual General Meeting (the “AGM”) on 26 June 2024 at 11.00 CEST at Advokatfirman Schjødt at Hamngatan 27, Stockholm, Sweden.Participation and notification of attendance A shareholder who wishes to participate in the AGM must (i) be recorded in the share register maintained by Euroclear Sweden AB relating to the circumstances on 17 June 2024 and (ii) no later than on 19 June 2024 give notice by post to Artificial Solutions International AB, “Annual General

atNorth Wins ‘Colocation Provider of the Year’ and ‘Digital Infrastructure Project of the Year’ at Industry Award Events

AtNorth recognized at the Electrical Review & Data Centre Review Awards and the Tech Capital Awards .Reykjavík, Iceland – May 24[th], 2024 – atNorth , the leading Nordic colocation, high-performance computing, and artificial intelligence service provider has today announced further acknowledgement in the industry as it wins two significant awards. The business has been awarded the ‘Colocation Provider of the Year’ award at the Electrical Review & Data Centre Review Awards .

A world-leading vehicle manufacturer is testing custom-made cell material from Smoltek

Smoltek Nanotech Holding AB (“Smoltek”) announces that one of the world's largest vehicle manufacturers is testing custom-made prototypes of a cell material that can significantly reduce the amount of iridium in an electrolyzer cell. The custom-made prototypes delivered by the subsidiary Smoltek Hydrogen have the potential to reduce the iridium load in electrolyzer cells by 95% compared to today's commercial materials, which is a prerequisite for large-scale production of fossil-free hydrogen.Smoltek Hydrogen, a wholly-owned subsidiary of the Smoltek Group, has developed a cell material

NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN OSSDSIGN AB

The shareholders in OssDsign AB, reg. no. 556841-7546, are hereby given notice to attend the annual general meeting at 10:00 am on Tuesday 25 June 2024 at Setterwalls Advokatbyrå’s offices at address Sturegatan 10 in Stockholm. Registration for the meeting commences 30 minutes before the opening of the meeting.The board of directors has decided, pursuant to Chapter 7, Section 4, Paragraph 2 of the Swedish Companies Act and the company’s articles of association, to apply the possibility of proxy collection in conjunction with the general meeting (se section Proxy collection below for more

Capsol Technologies ASA: Updated company presentation

Oslo, Norway – May 24, 2024Capsol Technologies ASA, a provider of carbon capture technology, has updatedits company presentation to reflect recent developments in the company and themarket.To adjust for inflation and market sentiment the company has made an upwardsadjustment of its licensing pricing model. The new target revenue range is EUR10-15 (real term) per ton installed CO2 capture capacity, from previously EUR7-12 per ton.Per Q1 2024, Capsol Technologies had secured three licensing agreements for theuse of its carbon capture technologies, six CapsolGo® demonstration

Peptonic publishes prospectus in connection with rights issue of units

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATIONOF THIS PRESS RELEASE WOULD BE UNLAWFULOR WOULD REQUIRE FURTHER REGISTRATION OR ANY OTHER MEASURES. PEPTONIC medical AB (publ) ("Peptonic” or the "Company") has prepared an EU growth prospectus (the "Prospectus") for the forthcoming issue of units consisting of shares and warrants with

Interim Financial Report – first three months of 2024 (Q1 2024)

Company announcement fromSGL Group ApS 24 May 2024 Company announcement no. 15 Q1 2024 results: SGL Group delivers according to planand maintain outlook for 2024 Today, SGL Group ApS has published its Interim Financial Report for the first three months of 2024 (Q1 2024). SGL Group delivered according to plan a solid performance in Q1 2024; driven by continuing solid ocean freight activity levels, despite macroeconomic events, and increased air freight activity levels, combined with continuing execution on complex logistic solution across various industries.   · Q1

OmniCar Holding AB – update regarding financial situation

The board of directors in OmniCar Holding AB (“OmniCar” or the “Company”) views that the Company must raise external capital to secure the Company’s continued business operations. For this reason, the board of directors has held talks regarding the financing of the Company and strategic alternatives with major shareholders and external investors. The board of directors has during these talks learnt that the major shareholders’ interest in supporting the Company – which historically has been very strong – going forward is very limited. As of today, discussions with external investors have

Lea bank ASA: Decision on Pillar 2 Requirement and Capital Buffer

The Norwegian Financial Supervisory Authority (FSA) has in connection with an updated assessment of risk and capital needs in Lea bank ASA ("SREP") made a decision on the capital requirement in Pillar 2 and the expected capital buffer. The Pillar 2 requirement and the expected capital buffer are in addition to the capital requirements under Pillar 1. The FSA has decided that the Pillar 2 requirement for Lea bank ASA shall be reduced from 6.5 % to 5.1 % of the total risk exposure amount. 100 % of the requirement must be covered with Core Equity Tier 1 (CET1). The FSA also expects Lea

Leqembi[®] approved for the treatment of Alzheimer’s disease in South Korea

Stockholm, Sweden, May 24, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the Ministry of Food and Drug Safety (MFDS) in South Korea published that Leqembi® (lecanemab) has been approved for treatment in patients with mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD (early AD).--- This information is information that BioArctic AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The information was released for public disclosure, through the agency of the contact persons below, on May 24, 2024, at 12:55 p.m. CET.

Form 8 (OPD) - Vukile Property Fund Ltd

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +------------------------------------------------+-----------------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+------------------------------------------------+-----------------------------+|(b) Owner or controller of interests and short |  ||positions disclosed, if different from

Form 8.3 - Wood Group (John) Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------------------+-------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------------------------+-------------------+|(b) Owner or controller of interests and short positions |  ||disclosed, if different from 1(a):

Capsol Technologies ASA: Approval and publication of prospectus and terms of the retail offering

Oslo, Norway – May 24, 2024NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INOR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS,ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE"UNITED STATES"), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGIONOF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, SOUTH AFRICA OR ANY OTHERJURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFULReference is made to the announcements on May 24, 2024, whereby Oslo Børs hasresolved to admit the

There are no items matching the current filter
There are no more items matching the current filter
Back to top